North America Viral Vector Purification Market to 2032
Overview
The North America Viral Vector Purification Market is expected to reach a 1,089.37 USD Million by 2032 and is projected to grow at a CAGR of 22.63% from 2025 to 2032.
Revenue, 2024 (USD Million)
381.26
Forecast, 2032 (USD Million)
1,089.37
CAGR, 2024 - 2032
22.63%
Report Coverage
North America
North America Viral Vector Purification Market 2018-2032 USD Million
North America Viral Vector Purification Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 381.26 USD Million
- Projected Market Size (2032): 1,089.37 USD Million
- CAGR (2025-2032): 22.63%
Key Findings of North America Viral Vector Purification Market
- The North America Viral Vector Purification Market was valued at 381.26 USD Million in 2024.
- The North America Viral Vector Purification Market is likely to grow at a CAGR of 22.63% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Upstream Processing in Workflow Segment accounted for the largest share of the market with a revenue of 337.13 USD Million
- The fastest growing segment Chromatography in Purification Technique Segment grew Fastest with a CAGR of 26.23% during the forecast period from 2024 to 2032.
North America Viral Vector Purification Market Scope
North America Viral Vector Purification Market Segmentation & Scope
End User
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organization (CDMO)
- Pharmaceutical Companies
- Academic/ Research Institutes
Application
- Antisense & RNAI
- Vaccinology
- Cell Therapy
- Gene Therapy
Delivery Mode
- Ex Vivo
- In Vivo
Disease Indication
- Other
- Cancer
- Veterinary Disease
- Infectious Diseases
- Genetic Disorders
Scale of Operation
- Commercial
- Preclinical / Clinical
Purification Technique
- Two-Phase Extraction Systems
- Precipitation
- Ultrafiltration
- Density-Gradient Ultracentrifugation
- Chromatography
By Type
- Vaccine Virus
- Retroviral Vectors
- Other
- Lentivirus
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
Workflow
- Downstream Processing
- Upstream Processing
Product & Services
- Services
- Products
North America Viral Vector Purification Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 381.26 USD Million |
| Market Value in 2032 | 1,089.37 USD Million |
| CAGR (2025-2032) | 22.63% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Application,Delivery Mode,Disease Indication,Scale of Operation,Purification Technique,By Type,Workflow,Product & Services |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 381.26 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 340.91 USD Million in 2024.
Segments and Scope
-
North America Viral Vector Purification Market to 2032, By End User
- Academic/ Research Institutes is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 162.46 USD Million in the year 2024.
- Academic/ Research Institutes is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 23.74 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By Application
- Gene Therapy is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 188.43 USD Million in the year 2024.
- Gene Therapy is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 25.24 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By Delivery Mode
- In Vivo is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 243.24 USD Million in the year 2024.
- In Vivo is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 24.10 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By Disease Indication
- Genetic Disorders is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 194.04 USD Million in the year 2024.
- Infectious Diseases is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 23.37 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By Scale of Operation
- Preclinical / Clinical is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 224.35 USD Million in the year 2024.
- Preclinical / Clinical is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 24.44 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By Purification Technique
- Chromatography is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 167.64 USD Million in the year 2024.
- Chromatography is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 26.23 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By By Type
- Adeno-Associated Viral Vectors is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 183.89 USD Million in the year 2024.
- Lentivirus is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 22.95 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By Workflow
- Upstream Processing is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 337.13 USD Million in the year 2024.
- Upstream Processing is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 22.97 % in forecast period 2025-2032.
-
North America Viral Vector Purification Market to 2032, By Product & Services
- Products is the largest segment in North America Viral Vector Purification Market to 2032 with a revenue of 289.40 USD Million in the year 2024.
- Products is the Fastest growing segment in North America Viral Vector Purification Market to 2032 with a Growth rate of 23.58 % in forecast period 2025-2032.
North America Viral Vector Purification Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| Agilent Technologies, Inc. | |||
| FUJIFILM Diosynth Biotechnologies | |||
| Cytiva | |||
North America Viral Vector Purification Market Geographical Sales Distribution, 2018-2032 USD Million
North America Viral Vector Purification Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Viral Vector Purification Market is segmented based on Segmentation End User,Application,Delivery Mode,Disease Indication,Scale of Operation,Purification Technique,By Type,Workflow,Product & Services.
North America Viral Vector Purification Market was valued at USD 381.26(Revenue in USD Million) in 2020.
North America Viral Vector Purification Market is projected to grow at a CAGR of 22.63% during the forecast period of 2024 to 2032.
The Upstream Processing segment is expected to dominate the North America Viral Vector Purification Market, holding a largest market share of 337.13 USD Million in 2024
North America Viral Vector Purification Market Scope
North America Viral Vector Purification Market Segmentation & Scope
End User
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organization (CDMO)
- Pharmaceutical Companies
- Academic/ Research Institutes
Application
- Antisense & RNAI
- Vaccinology
- Cell Therapy
- Gene Therapy
Delivery Mode
- Ex Vivo
- In Vivo
Disease Indication
- Other
- Cancer
- Veterinary Disease
- Infectious Diseases
- Genetic Disorders
Scale of Operation
- Commercial
- Preclinical / Clinical
Purification Technique
- Two-Phase Extraction Systems
- Precipitation
- Ultrafiltration
- Density-Gradient Ultracentrifugation
- Chromatography
By Type
- Vaccine Virus
- Retroviral Vectors
- Other
- Lentivirus
- Adenoviral Vectors
- Adeno-Associated Viral Vectors
Workflow
- Downstream Processing
- Upstream Processing
Product & Services
- Services
- Products
Frequently Asked Questions
The North America Viral Vector Purification Market is segmented based on Segmentation End User,Application,Delivery Mode,Disease Indication,Scale of Operation,Purification Technique,By Type,Workflow,Product & Services.
North America Viral Vector Purification Market was valued at USD 381.26(Revenue in USD Million) in 2020.
North America Viral Vector Purification Market is projected to grow at a CAGR of 22.63% during the forecast period of 2024 to 2032.
The estimated market value of the North America Viral Vector Purification Market for final year is USD 1,089.37 (USD Million).
North America Viral Vector Purification Market Company Profiling
Frequently Asked Questions
The North America Viral Vector Purification Market is segmented based on Segmentation End User,Application,Delivery Mode,Disease Indication,Scale of Operation,Purification Technique,By Type,Workflow,Product & Services.
North America Viral Vector Purification Market was valued at USD 381.26(Revenue in USD Million) in 2020.
North America Viral Vector Purification Market is projected to grow at a CAGR of 22.63% during the forecast period of 2024 to 2032.
The estimated market value of the North America Viral Vector Purification Market for final year is USD 1,089.37 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.